Rick Wise
Stock Analyst at Stifel
(4.29)
# 380
Out of 4,944 analysts
242
Total ratings
62.56%
Success rate
10.73%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Maintains: Hold | $9 → $6 | $6.54 | -8.26% | 9 | Aug 8, 2025 | |
| AORT Artivion | Maintains: Buy | $36 → $40 | $43.85 | -8.78% | 7 | Aug 8, 2025 | |
| BAX Baxter International | Downgrades: Hold | $36 → $25 | $23.98 | +4.25% | 9 | Aug 4, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $5 | $1.59 | +214.47% | 5 | Jul 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $90 → $95 | $76.93 | +23.49% | 24 | Jul 25, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $101.82 | +12.94% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $194.96 | +14.90% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $54.01 | +1.83% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $131.02 | +10.67% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $15.03 | +86.29% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $32 | $19.66 | +62.77% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $60 | $50.64 | +18.48% | 6 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $35.82 | +34.00% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $120 | $102.64 | +16.91% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $376.61 | +16.83% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $172.78 | -10.29% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $478.19 | +27.56% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $150.13 | +26.56% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $72.09 | +13.75% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $74.41 | +37.08% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $92.08 | -5.52% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.56 | +115.83% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $94.38 | -20.53% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $11.11 | +116.12% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $12.67 | +610.34% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $10.79 | +131.70% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $41.22 | +171.71% | 5 | Oct 2, 2020 |
Treace Medical Concepts
Aug 8, 2025
Maintains: Hold
Price Target: $9 → $6
Current: $6.54
Upside: -8.26%
Artivion
Aug 8, 2025
Maintains: Buy
Price Target: $36 → $40
Current: $43.85
Upside: -8.78%
Baxter International
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $23.98
Upside: +4.25%
Pulmonx
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.59
Upside: +214.47%
Edwards Lifesciences
Jul 25, 2025
Maintains: Buy
Price Target: $90 → $95
Current: $76.93
Upside: +23.49%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $101.82
Upside: +12.94%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $194.96
Upside: +14.90%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $54.01
Upside: +1.83%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $131.02
Upside: +10.67%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $15.03
Upside: +86.29%
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $19.66
Upside: +62.77%
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $50.64
Upside: +18.48%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $35.82
Upside: +34.00%
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $102.64
Upside: +16.91%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $376.61
Upside: +16.83%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $172.78
Upside: -10.29%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $478.19
Upside: +27.56%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $150.13
Upside: +26.56%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $72.09
Upside: +13.75%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $74.41
Upside: +37.08%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $92.08
Upside: -5.52%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.56
Upside: +115.83%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $94.38
Upside: -20.53%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $11.11
Upside: +116.12%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $12.67
Upside: +610.34%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $10.79
Upside: +131.70%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $41.22
Upside: +171.71%